Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of 133.98 billion as of May 30, 2025. Its market cap has increased by 42.50% in one year.

Market Cap

133.98B

Enterprise Value

149.28B

Revenue

22.16B

Ranking

n/a

PE Ratio

13.51

Stock Price

1,017.50

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 133.98B, an increase of 6,795.44%. That is a compound annual growth rate of 22.27%.

Market Cap History

Date	Market Cap	% Change
May 30, 2025	133.98B	5.71%
Dec 31, 2024	126.75B	53.56%
Dec 29, 2023	82.54B	-45.00%
Dec 30, 2022	150.07B	29.37%
Dec 31, 2021	116.00B	1.13%
Dec 31, 2020	114.71B	134.71%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,108.82B
Grupo Financiero Banorte	477.92B
Arca Continental	361.37B
GMéxico Transportes	156.66B
FIBRA Prologis	119.22B
Fibra UNO	103.85B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	91.59B
Becle	83.10B

Market Cap Rankings